Publications

Publications published since 2010 from OUS - Section for head and neck oncology

85 publications found

Publications 2019

  1. Bains SJ, Niehusmann PF, Meling TR, Saxhaug C, Züchner M, Brandal P (2019)
    Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease-a case report and literature review
    Acta Neurochir (Wien), 161 (2), 343-349
    DOI 10.1007/s00701-019-03800-z, PubMed 30652202
  2. Bjune K, Høyer E, Schanke AK, Brandal P (2019)
    Behov for rehabilitering etter hjernesvulst
    Tidsskr Nor Laegeforen, 139 (10)
    DOI 10.4045/tidsskr.19.0268, PubMed 31238657
  3. Bogsrud TV, Londalen A, Brandal P, Leske H, Panagopoulos I, Borghammer P, Bach-Gansmo T (2019)
    18F-Fluciclovine PET/CT in Suspected Residual or Recurrent High-Grade Glioma
    Clin Nucl Med, 44 (8), 605-611
    DOI 10.1097/RLU.0000000000002641, PubMed 31274605
  4. Brandstorp-Boesen J, Zätterström U, Evensen JF, Boysen M (2019)
    Value of patient-reported symptoms in the follow up of patients potentially cured of laryngeal carcinoma
    J Laryngol Otol, 133 (6), 508-514
    DOI 10.1017/S0022215119000677, PubMed 31006407
  5. Evensen JF, Sand Hansen H, Overgaard M, Johansen J, Andersen LJ, Overgaard J (2019)
    DAHANCA 9 - a randomized multicenter study to compare accelerated normo-fractionated radiotherapy with accelerated hyperfractionated radiotherapy in patients with primary squamous cell carcinoma of the head and neck (HNSCC)
    Acta Oncol
    DOI 10.1080/0284186X.2019.1629012, PubMed 31282236
  6. Latysheva A, Emblem KE, Brandal P, Vik-Mo EO, Pahnke J, Røysland K, Hald JK, Server A (2019)
    Dynamic susceptibility contrast and diffusion MR imaging identify oligodendroglioma as defined by the 2016 WHO classification for brain tumors: histogram analysis approach
    Neuroradiology, 61 (5), 545-555
    DOI 10.1007/s00234-019-02173-5, PubMed 30712139
  7. Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Stensvold E, Due-Tønnessen P (2019)
    Adult outcome after neurosurgical treatment of brain tumours in the first year of life: long-term follow-up of a single consecutive institutional series of 34 patients
    Acta Neurochir (Wien) (in press)
    DOI 10.1007/s00701-019-04014-z, PubMed 31309304
  8. Moan JM, Amdal CD, Malinen E, Svestad JG, Bogsrud TV, Dale E (2019)
    The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status
    Radiother Oncol, 140, 54-61 (in press)
    DOI 10.1016/j.radonc.2019.05.019, PubMed 31177043
  9. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, Santos M, Inhestern J, Brannan C, Yarom N, Fullerton A, Pinto M, Arraras JI, Kiyota N, Bonomo P, Sherman AC, Baumann I, Galalae R, Fernandez Gonzalez L, Nicolatou-Galitis O, Abdel-Hafeez Z, Raber-Durlacher J, Schmalz C, Zotti P, Boehm A et al. (2019)
    International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV
    Head Neck, 41 (6), 1725-1737
    DOI 10.1002/hed.25609, PubMed 30636188
  10. Stensvold E, Myklebust TÅ, Cappelen J, Due-Tønnessen BJ, Due-Tønnessen P, Kepka A, Johannesen TB, Krossnes B, Lundar T, Maric S, Miletic H, Moholdt V, Myrmel KS, Nordberg T, Rydland J, Stokland T, Solem K, Solheim O, Torsvik I, Wikran GC, Zeller B, Wesenberg F, Bechensteen AG, Brandal P (2019)
    Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival
    Pediatr Blood Cancer, e27910
    DOI 10.1002/pbc.27910, PubMed 31264356
  11. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP (2019)
    Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy
    Acta Oncol, 1-7 (in press)
    DOI 10.1080/0284186X.2019.1643496, PubMed 31364899
  12. Sunde B, Johnsen G, Jacobsen AB, Glenjen NI, Friesland S, Lindblad M, Rouvelas I, Wang N, Lundell L, Lagergren P, Nilsson M (2019)
    Effects of neoadjuvant chemoradiotherapy vs chemotherapy alone on the relief of dysphagia in esophageal cancer patients: secondary endpoint analysis in a randomized trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy069, PubMed 30084992
  13. von Döbeln GA, Klevebro F, Jacobsen AB, Johannessen HO, Nielsen NH, Johnsen G, Hatlevoll I, Glenjen NI, Friesland S, Lundell L, Yu J, Nilsson M (2019)
    Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial
    Dis Esophagus, 32 (2)
    DOI 10.1093/dote/doy078, PubMed 30137281

Publications 2018

  1. Brøndum L, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Evensen JF, Kristensen CA, Andersen LJ, Overgaard J, Eriksen JG (2018)
    Associations between skin rash, treatment outcome, and single nucleotide polymorphisms in head and neck cancer patients receiving the EGFR-inhibitor zalutumumab: results from the DAHANCA 19 trial
    Acta Oncol, 57 (9), 1159-1164
    DOI 10.1080/0284186X.2018.1464664, PubMed 29771169
  2. Dale E, Waldeland E (2018)
    Proton therapy - a reality in Norway from 2023
    Tidsskr Nor Laegeforen, 138 (13)
    DOI 10.4045/tidsskr.18.0250, PubMed 30180494
  3. Enden T, Bernklev T, Jelsness-Jorgensen LP, Amdal CD (2018)
    Patients know their own health best
    Tidsskr. Nor. Laegeforen., 138 (8), 716-718
  4. Johannessen LE, Brandal P, Myklebust TÅ, Heim S, Micci F, Panagopoulos I (2018)
    MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas
    Cancer Genomics Proteomics, 15 (6), 437-446
    DOI 10.21873/cgp.20102, PubMed 30343277
  5. Lundar T, Due-Tønnessen BJ, Fric R, Egge A, Krossnes B, Due-Tønnessen P, Stensvold E, Brandal P (2018)
    Neurosurgical treatment of gangliogliomas in children and adolescents: long-term follow-up of a single-institution series of 32 patients
    Acta Neurochir (Wien), 160 (6), 1207-1214
    DOI 10.1007/s00701-018-3550-8, PubMed 29680921
  6. Overgaard J, Hoff CM, Hansen HS, Specht L, Overgaard M, Lassen P, Andersen E, Johansen J, Andersen LJ, Evensen JF, Alsner J, Grau C (2018)
    DAHANCA 10 - Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group
    Radiother Oncol, 127 (1), 12-19
    DOI 10.1016/j.radonc.2018.02.018, PubMed 29523409
  7. Panagopoulos I, Gorunova L, Leske H, Niehusmann P, Johannessen LE, Staurseth J, Øino N, Meling TR, Heim S, Micci F, Brandal P (2018)
    Pyrosequencing Analysis of MGMT Promoter Methylation in Meningioma
    Cancer Genomics Proteomics, 15 (5), 379-385
    DOI 10.21873/cgp.20096, PubMed 30194078
  8. Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, Malinen E, Dale E (2018)
    Dose painting for re-irradiation of head and neck cancer
    Acta Oncol, 57 (12), 1693-1699
    DOI 10.1080/0284186X.2018.1512753, PubMed 30280623

Publications 2017

  1. Amdal CD, Jacobsen AB, Falk RS, Johnson E, Os SS, Warloe T, Bjordal K (2017)
    Improved treatment decisions in patients with esophageal cancer
    Acta Oncol, 56 (10), 1286-1294
    DOI 10.1080/0284186X.2017.1346379, PubMed 28686501
  2. Astrup GL, Hofsø K, Bjordal K, Guren MG, Vistad I, Cooper B, Miaskowski C, Rustøen T (2017)
    Patient factors and quality of life outcomes differ among four subgroups of oncology patients based on symptom occurrence
    Acta Oncol, 56 (3), 462-470
    DOI 10.1080/0284186X.2016.1273546, PubMed 28077018
  3. Astrup GL, Rustøen T, Hofsø K, Gran JM, Bjordal K (2017)
    Symptom burden and patient characteristics: Association with quality of life in patients with head and neck cancer undergoing radiotherapy
    Head Neck, 39 (10), 2114-2126
    DOI 10.1002/hed.24875, PubMed 28766791
  4. Jacobsen AB, Grøholt KK, Lorntzsen B, Osnes TA, Falk RS, Sigstad E (2017)
    Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery
    Eur Arch Otorhinolaryngol, 274 (12), 4203-4209
    DOI 10.1007/s00405-017-4764-8, PubMed 29019001
  5. Johansen S, Norman MH, Dale E, Amdal CD, Furre T, Malinen E, Evensen JF (2017)
    Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer
    Radiat Oncol, 12 (1), 87
    DOI 10.1186/s13014-017-0829-5, PubMed 28545588
  6. König M, Osnes T, Jebsen P, Evensen JF, Meling TR (2017)
    Olfactory neuroblastoma: a single-center experience
    Neurosurg Rev, 41 (1), 323-331
    DOI 10.1007/s10143-017-0859-3, PubMed 28540633
  7. Leske H, Brandal P, Rushing EJ, Niehusmann P (2017)
    IDH-mutant giant cell glioblastoma: A neglected tumor variant?
    Clin Neuropathol, 36 (6), 293-295
    DOI 10.5414/NP301054, PubMed 29035191
  8. Mikalsen LTG, Arnesen MR, Bogsrud TV, Dale E, Stokke C (2017)
    Combining radioiodine and external beam radiation therapy: the potential of integrated treatment planning for differentiated thyroid cancer
    Acta Oncol, 56 (6), 894-897
    DOI 10.1080/0284186X.2017.1286384, PubMed 28464741
  9. Mäkitie AA, Cange HH, Hammarstedt-Nordenvall L, Gudjonsson A, Jóhannsson J, Laranne J, Mäenpää H, Rikardsen O, Bratland Å, Wessel I, Johansen J, Grau C (2017)
    Head and neck cancer management in the Nordic countries: an effort to harmonize treatment
    Eur Arch Otorhinolaryngol, 274 (5), 2363-2365
    DOI 10.1007/s00405-017-4456-4, PubMed 28124110
  10. Stensvold E, Krossnes BK, Lundar T, Due-Tønnessen BJ, Frič R, Due-Tønnessen P, Bechensteen AG, Myklebust TÅ, Johannesen TB, Brandal P (2017)
    Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment
    Acta Oncol, 56 (5), 698-705
    DOI 10.1080/0284186X.2017.1301679, PubMed 28325133

Publications 2016

  1. Boysen ME, Zätterström UK, Evensen JF (2016)
    Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases
    Anticancer Res, 36 (6), 2849-54
    PubMed 27272796
  2. Dale E, Moan JM, Osnes TA, Bogsrud TV (2016)
    Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome
    Eur Arch Otorhinolaryngol, 274 (2), 1015-1019
    DOI 10.1007/s00405-016-4318-5, PubMed 27671150
  3. Gulati G, Heck SL, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, von Knobelsdorff-Brenkenhoff F, Bratland Å, Storås TH, Hagve TA, Røsjø H, Steine K, Geisler J, Omland T (2016)
    Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
    Eur Heart J, 37 (21), 1671-80
    DOI 10.1093/eurheartj/ehw022, PubMed 26903532
  4. Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, Nicolatou-Galitis O, Pinto M, Raber-Durlacher J, Singer S, Tomaszewska IM, Tomaszewski KA, Verdonck-de Leeuw I, Yarom N, Winstanley JB, Herlofson BB, EORTC QoL Group (2016)
    International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15
    Support Care Cancer, 24 (9), 3915-24
    DOI 10.1007/s00520-016-3216-0, PubMed 27113466
  5. Klevebro F, Alexandersson von Döbeln G, Wang N, Johnsen G, Jacobsen AB, Friesland S, Hatlevoll I, Glenjen NI, Lind P, Tsai JA, Lundell L, Nilsson M (2016)
    A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction
    Ann Oncol, 27 (4), 660-7
    DOI 10.1093/annonc/mdw010, PubMed 26782957
  6. Olsen TK, Panagopoulos I, Gorunova L, Micci F, Andersen K, Kilen Andersen H, Meling TR, Due-Tønnessen B, Scheie D, Heim S, Brandal P (2016)
    Novel fusion genes and chimeric transcripts in ependymal tumors
    Genes Chromosomes Cancer, 55 (12), 944-953
    DOI 10.1002/gcc.22392, PubMed 27401149
  7. Vandraas K, Tjønnfjord GE, Johannesen TB, Brandal P (2016)
    Persistent bone marrow depression following short-term treatment with temozolomide
    BMJ Case Rep, 2016
    DOI 10.1136/bcr-2016-215797, PubMed 27130558
  8. Varghese M, Nymoen HG, Saxhaug C, Krossnes B, Abdol Mohieb Hosainey S, Meling TR, Brandal P (2016)
    Symptomatic spinal metastasis from intracranial glioblastoma multiforme - Two illustrative cases and a review of the literature
    Acta Oncol, 55 (9-10), 1236-1238
    DOI 10.3109/0284186X.2016.1161824, PubMed 27174685

Publications 2015

  1. Arnesen MR, Knudtsen IS, Rekstad BL, Eilertsen K, Dale E, Bruheim K, Helland Å, Løndalen AM, Hellebust TP, Malinen E (2015)
    Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps
    Acta Oncol, 54 (9), 1607-13
    DOI 10.3109/0284186X.2015.1061690, PubMed 26213311
  2. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
    A Longitudinal Study of Depressive Symptoms in Patients With Head and Neck Cancer Undergoing Radiotherapy
    Cancer Nurs, 38 (6), 436-46
    DOI 10.1097/NCC.0000000000000225, PubMed 25643005
  3. Astrup GL, Rustøen T, Miaskowski C, Paul SM, Bjordal K (2015)
    Changes in and predictors of pain characteristics in patients with head and neck cancer undergoing radiotherapy
    Pain, 156 (5), 967-79
    DOI 10.1097/j.pain.0000000000000142, PubMed 25719616
  4. Cehajic I, Bergan S, Bjordal K (2015)
    Pharmacist assessment of drug-related problems on an oncology ward
    Eur. J. Hosp. Pharm.-Sci. Pract., 22 (4), 194-197
  5. Due-Tønnessen BJ, Egge A, Lundar T, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
    Posterior fossa ependymoblastoma diagnosed in the second month of life: uneventful 12 years survival after gross total resection followed by chemotherapy
    Springerplus, 4, 389
    DOI 10.1186/s40064-015-1178-1, PubMed 26251773
  6. Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E, Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell L, Nilsson M (2015)
    Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation
    Eur J Surg Oncol, 41 (7), 920-6
    DOI 10.1016/j.ejso.2015.03.226, PubMed 25908010
  7. Lundar T, Due-Tønnessen BJ, Egge A, Krossnes B, Stensvold E, Due-Tønnessen P, Brandal P (2015)
    Neurosurgical treatment of brain tumors in the first 6 months of life: long-term follow-up of a single consecutive institutional series of 30 patients
    Childs Nerv Syst, 31 (12), 2283-90
    DOI 10.1007/s00381-015-2792-5, PubMed 26174616
  8. Lyhne NM, Primdahl H, Kristensen CA, Andersen E, Johansen J, Andersen LJ, Evensen J, Mortensen HR, Overgaard J (2015)
    The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma
    Radiother Oncol, 117 (1), 91-8
    DOI 10.1016/j.radonc.2015.07.004, PubMed 26255764

Publications 2014

  1. Dale E (2014)
    [Re: Brachytherapy for malignant uveal melanoma]
    Tidsskr Nor Laegeforen, 134 (8), 814
    DOI 10.4045/tidsskr.14.0467, PubMed 24780973
  2. Hofsø K, Bjordal K, Diep LM, Rustøen T (2014)
    The relationships between demographic and clinical characteristics and quality of life during and after radiotherapy: in women with breast cancer
    Qual Life Res, 23 (10), 2769-77
    DOI 10.1007/s11136-014-0736-2, PubMed 24952109
  3. Lassen P, Primdahl H, Johansen J, Kristensen CA, Andersen E, Andersen LJ, Evensen JF, Eriksen JG, Overgaard J, Danish Head and Neck Cancer Group (DAHANCA) (2014)
    Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer
    Radiother Oncol, 113 (3), 310-6
    DOI 10.1016/j.radonc.2014.11.032, PubMed 25544647
  4. Lundar T, Due-Tønnessen BJ, Egge A, Scheie D, Brandal P, Stensvold E, Due-Tønnessen P (2014)
    Neurosurgical treatment of pediatric low-grade midbrain tumors: a single consecutive institutional series of 15 patients
    J Neurosurg Pediatr, 14 (6), 598-603
    DOI 10.3171/2014.9.PEDS1462, PubMed 25325421
  5. Lundar T, Due-Tønnessen BJ, Scheie D, Brandal P (2014)
    Pediatric spinal ependymomas: an unpredictable and puzzling disease. Long-term follow-up of a single consecutive institutional series of ten patients
    Childs Nerv Syst, 30 (12), 2083-8
    DOI 10.1007/s00381-014-2491-7, PubMed 25079883
  6. von der Lippe C, Roscher I, Nordgarden H, Rustad C, Larsen SM, Mjøen E, Bratland Å (2014)
    Man with macrocephaly, learning disability and multiple basal cell carcinomas
    Tidsskr Nor Laegeforen, 134 (11), 1151-4
    DOI 10.4045/tidsskr.13.0894, PubMed 24939783
  7. Zätterström U, Boysen M, Evensen JF (2014)
    Significance of self-reported symptoms as part of follow-up routines in patients treated for oral squamous cell carcinoma
    Anticancer Res, 34 (11), 6593-9
    PubMed 25368263

Publications 2013

  1. Amdal CD, Jacobsen AB, Sandstad B, Warloe T, Bjordal K (2013)
    Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial
    Radiother Oncol, 107 (3), 428-33
    DOI 10.1016/j.radonc.2013.04.008, PubMed 23647761
  2. Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T (2013)
    [Cardioprotective treatment during adjuvant cancer therapy]
    Tidsskr Nor Laegeforen, 133 (17), 1832-6
    DOI 10.4045/tidsskr.12.1514, PubMed 24042297
  3. Håvik AB, Lind GE, Honne H, Meling TR, Scheie D, Hall KS, van den Berg E, Mertens F, Picci P, Lothe RA, Heim S, Brandal P (2013)
    Sequencing IDH1/2 glioma mutation hotspots in gliomas and malignant peripheral nerve sheath tumors
    Neuro Oncol, 16 (2), 320-2
    DOI 10.1093/neuonc/not230, PubMed 24311631
  4. Lundar T, Due-Tønnessen BJ, Egge A, Scheie D, Stensvold E, Brandal P (2013)
    Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients
    J Neurosurg Pediatr, 12 (3), 241-6
    DOI 10.3171/2013.6.PEDS12586, PubMed 23870041
  5. Mortensen HR, Overgaard J, Jensen K, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen E, Andersen LJ, Hansen HS, Grau C, DAHANCA Group (2013)
    Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer
    Acta Oncol, 52 (7), 1535-42
    DOI 10.3109/0284186X.2013.824609, PubMed 24047339
  6. Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King MT, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A, Patient Reported Outcomes and Behavioral Evidence (PROBE) and the European Organization for Research and Treatment of Cancer (EORTC) Clinical Groups (2013)
    A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites
    Cancer, 120 (2), 302-11
    DOI 10.1002/cncr.28382, PubMed 24127333
  7. Rogne SG, Helseth E, Brandal P, Scheie D, Meling TR (2013)
    Are melanomas averse to cerebellum? Cerebellar metastases in a surgical series
    Acta Neurol Scand, 130 (1), 1-10
    DOI 10.1111/ane.12206, PubMed 24313862
  8. Røe K, Bratland Å, Vlatkovic L, Ragnum HB, Saelen MG, Olsen DR, Marignol L, Ree AH (2013)
    Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer
    PLoS One, 8 (5), e63723
    DOI 10.1371/journal.pone.0063723, PubMed 23675504

Publications 2012

  1. Amdal CD, Jacobsen AB, Guren MG, Bjordal K (2012)
    Patient-reported outcomes evaluating palliative radiotherapy and chemotherapy in patients with oesophageal cancer: a systematic review
    Acta Oncol, 52 (4), 679-90
    DOI 10.3109/0284186X.2012.731521, PubMed 23190360
  2. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2012)
    Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients
    J Pain Symptom Manage, 43 (4), 694-705
    DOI 10.1016/j.jpainsymman.2011.05.008, PubMed 22285284
  3. Heck SL, Gulati G, Ree AH, Schulz-Menger J, Gravdehaug B, Røsjø H, Steine K, Bratland A, Hoffmann P, Geisler J, Omland T (2012)
    Rationale and design of the prevention of cardiac dysfunction during an Adjuvant Breast Cancer Therapy (PRADA) Trial
    Cardiology, 123 (4), 240-7
    DOI 10.1159/000343622, PubMed 23207160
  4. Hofsø K, Miaskowski C, Bjordal K, Cooper BA, Rustøen T (2012)
    Previous chemotherapy influences the symptom experience and quality of life of women with breast cancer prior to radiation therapy
    Cancer Nurs, 35 (3), 167-77
    DOI 10.1097/NCC.0b013e31821f5eb5, PubMed 21760482
  5. Hofsø K, Rustøen T, Cooper BA, Bjordal K, Miaskowski C (2012)
    Changes over time in occurrence, severity, and distress of common symptoms during and after radiation therapy for breast cancer
    J Pain Symptom Manage, 45 (6), 980-1006
    DOI 10.1016/j.jpainsymman.2012.06.003, PubMed 23026547
  6. Håvik AB, Brandal P, Honne H, Dahlback HS, Scheie D, Hektoen M, Meling TR, Helseth E, Heim S, Lothe RA, Lind GE (2012)
    MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR
    J Transl Med, 10, 36
    DOI 10.1186/1479-5876-10-36, PubMed 22390413
  7. Larsson C, Kleppestø M, Rasmussen I, Salo R, Vardal J, Brandal P, Bjørnerud A (2012)
    Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results
    J Magn Reson Imaging, 37 (4), 818-29
    DOI 10.1002/jmri.23866, PubMed 23086710
  8. Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, Andersen LJ, Andersen E, Grau C (2012)
    Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6&7 randomised trial with accelerated radiotherapy for head and neck cancer
    Radiother Oncol, 103 (1), 69-75
    DOI 10.1016/j.radonc.2012.01.002, PubMed 22398313
  9. Skretting A, Evensen JF, Løndalen AM, Bogsrud TV, Glomset OK, Eilertsen K (2012)
    A gel tumour phantom for assessment of the accuracy of manual and automatic delineation of gross tumour volume from FDG-PET/CT
    Acta Oncol, 52 (3), 636-44
    DOI 10.3109/0284186X.2012.718095, PubMed 23075421

Publications 2011

  1. Amdal CD, Jacobsen AB, Tausjø JE, Wiig JN, Warloe T, Sandstad B, Bjordal K (2011)
    Palliative interventions and prognosis in patients with advanced esophageal cancer
    Dis Esophagus, 24 (7), 502-9
    DOI 10.1111/j.1442-2050.2010.01174.x, PubMed 21309923
  2. Andreassen TN, Eftedal I, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2011)
    Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study
    Eur J Clin Pharmacol, 68 (1), 55-64
    DOI 10.1007/s00228-011-1093-5, PubMed 21735164
  3. Dahlback HS, Brandal P, Gorunova L, Widing E, Meling TR, Krossnes BK, Heim S (2011)
    Genomic aberrations in pediatric gliomas and embryonal tumors
    Genes Chromosomes Cancer, 50 (10), 788-99
    DOI 10.1002/gcc.20898, PubMed 21717527
  4. Dahlback HS, Brandal P, Krossnes BK, Fric R, Meling TR, Meza-Zepeda LA, Danielsen HE, Heim S (2011)
    Multiple chromosomal monosomies are characteristic of giant cell ependymoma
    Hum Pathol, 42 (12), 2042-6
    DOI 10.1016/j.humpath.2011.02.012, PubMed 21683982
  5. Dahlback HS, Gorunova L, Brandal P, Scheie D, Helseth E, Meling TR, Heim S (2011)
    Genomic aberrations in diffuse low-grade gliomas
    Genes Chromosomes Cancer, 50 (6), 409-20
    DOI 10.1002/gcc.20866, PubMed 21412929
  6. Dahlback HS, Gorunova L, Micci F, Scheie D, Brandal P, Meling TR, Heim S (2011)
    Molecular cytogenetic analysis of a gliosarcoma with osseous metaplasia
    Cytogenet Genome Res, 134 (2), 88-95
    DOI 10.1159/000326804, PubMed 21555877
  7. Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
    Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
    Acta Oncol, 50 (7), 1068-74
    DOI 10.3109/0284186X.2011.585998, PubMed 21745131
  8. Hoff CM, Lassen P, Eriksen JG, Hansen HS, Specht L, Overgaard M, Grau C, Johansen J, Bentzen J, Andersen L, Evensen JF, Overgaard J (2011)
    Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials
    Acta Oncol, 50 (7), 1006-14
    DOI 10.3109/0284186X.2011.592650, PubMed 21790306
  9. Klepstad P, Fladvad T, Skorpen F, Bjordal K, Caraceni A, Dale O, Davies A, Kloke M, Lundström S, Maltoni M, Radbruch L, Sabatowski R, Sigurdardottir V, Strasser F, Fayers PM, Kaasa S, European Palliative Care Research Collaborative (EPCRC), European Association for Palliative Care Research Network (2011)
    Influence from genetic variability on opioid use for cancer pain: a European genetic association study of 2294 cancer pain patients
    Pain, 152 (5), 1139-45
    DOI 10.1016/j.pain.2011.01.040, PubMed 21398039
  10. Kyriazoglou AI, Dimitriadis E, Arnogiannaki N, Brandal P, Heim S, Pandis N (2011)
    Similar cytogenetic findings in two synchronous secondary peripheral chondrosarcomas in a patient with multiple osteochondromas
    Cancer Genet, 204 (12), 677-81
    DOI 10.1016/j.cancergen.2011.10.013, PubMed 22285020

Publications 2010

  1. Andreassen TN, Klepstad P, Davies A, Bjordal K, Lundström S, Kaasa S, Dale O (2010)
    Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients
    Eur J Clin Pharmacol, 67 (5), 493-506
    DOI 10.1007/s00228-010-0948-5, PubMed 21140139
  2. Dale E, Hårsaker V, Kristoffersen DT, Bruland O, Olsen DR (2010)
    CT density in lung cancer patients after radiotherapy sensitized by metoclopramide. A subgroup analysis of a randomized trial
    Strahlenther Onkol, 186 (3), 163-8
    DOI 10.1007/s00066-010-2040-6, PubMed 20165821
  3. Utne I, Miaskowski C, Bjordal K, Paul SM, Rustoen T (2010)
    The relationships between mood disturbances and pain, hope, and quality of life in hospitalized cancer patients with pain on regularly scheduled opioid analgesic
    J Palliat Med, 13 (3), 311-8
    DOI 10.1089/jpm.2009.0294, PubMed 20078225
  4. Wranicz P, Herlofson BB, Evensen JF, Kongsgaard UE (2010)
    Prevention and treatment of trismus in head and neck cancer: A case report and a systematic review of the literature
    Scand J Pain, 1 (2), 84-88
    DOI 10.1016/j.sjpain.2010.01.006, PubMed 29913945
 
Page visits: 2970